Adverse hepatic effects associated with administration of antiretroviral drugs (nevirapine, lamivudine and stavudine) to albino rats: Implication for management of patients with HIV/AIDS

Asian Journal of Biochemistry

Volumn 3, Issue 1, 2008, Pages 19-25

  Umar, R A ^a   Hassan, S W ^a   Ladan, M J ^a   Matazu, I K ^a   Shehu, B ^b   Shehu, R A ^a   Muhammed, L G ^a   Molabo, F I ^a  

^a USMANU DANFODIYO UNIVERSITY   (Nigeria)

^b Laboratory Services Unit   (Nigeria)

Author keywords

Administration; Adverse hepatic effects; Albino rats; Antiretroviral drugs; Hepatotoxicity; HIV AIDS management

Indexed keywords

RATTUS;

EID: 41149138044     PISSN: 18159923     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajb.2008.19.25     Document Type: Article

References (38)

1. Abatan, M.O., R.O.A. Arowolo and O. Olorunsogo, 1996. Pathological effects of Lantana camara and Dichapetalum madagascasiense in goats. Trop. Vet. Med., 14: 127-132.
2. Anderson, N., 2005. Western and traditional African medicine: Working together on AIDS. Br. Med. J., 331: 785-786.
3. Anonymous, 2000. Serious adverse events attributed to nevirapine regimens for post-exposure prophylaxis after HIV exposures world wide. Morbidity and Mortality Weekly Report, Center for Disease Control, 49: 1997-2001.
4. Anonymous, 2001. HIV/Syphilis Sentinal Sero Prevalence Survey in Nigeria. Information for Policy Makers, pp: 30-50.
5. Anonymous, 2003. Study confirms effectiveness of antiretroviral drugs for HIV patients. Lancet, 362: 1267-1274.
6. Bartlett, J.G. and J.E. Gallant, 2003. Natural history and classification in management of HIV infection. John Hopkins University, Baltimore.
7. Beaunc, P., P.M. Dansette and D. Mansuy, 1987. Human anti-endoplasmic reficulum auto antibodies appearing in a drug-induced hepatitis are directed against human liver cytochrome P-450 that hydroxylates the drug. Proc. Nat. Acad. Sci. USA., 84: 551-555.
8. Benjamin, M.N., 1978. Outline of Veterinary Clinical Pathology. University Press, Iowa, USA., pp: 229-232.
9. Fauci, A.S., 2006. Editorial: Twenty five years of HIV/AIDS. Science, 313: 409-409.
10. Fistche, M.A., C.B. Parker and C. Pettineli, 1990. A randomized controlled trial of reduced daily dose of Zidovudine in patients with AIDS. N. Eng. J. Med., 323: 200-202.
11. Gebrekristos, H.T., K.P. Mlisane and Q. AbdelKarim, 2005. Assessing patients'readiness to start antiretroviral therapy. Br. Med. J., 331: 772-773.
12. Gottlieb, M.S., H.M. Schanker and A. Fan, 1981. Pneumocystis pneumonia in Los Angeles. Morbidity and Mortality Weekly Report. Center for Disease Control and Prevention, Atlanta, Georgia, 30: 250-252.
13. Goulder, P.J. and D.I. Watkins, 2004. HIV and SIV CTL escape: Implication for vaccine design. Nat. Rev. Immunol., 4: 630-640.
14. Goulder, P.J., 2006. A deadly struggle: HIV versus the human immune system. Wellcome Science, pp: 21-23.
15. Hache, C. and J. Villeneure, 2006. Lamivudine treatment in patients with chronic hepatitis B and cirrhosis. Exp. Opin. Pharmacother., 17: 835-843.
16. Haines, A. 2003. Editorial. Shaping the firture of global health. Bull. World Health Organ., 81: 855-855.
17. Johnson, S. and J.G. Baraboutis, 2000. Adverse effects associated with the use of nevirapine in HIV post exposure prophylaxis for 2 health care workers. JAMA., 284: 2722-2723.
18. King, E.J., 1951. Determination of Proteins. In: Recent Advances in Clinical Pathology. Dyke, S.C. (Ed.), 2nd Edn., J and A Churchill, London.
19. Lee, W.M., 2003. Drug-induced hepatotoxicity. New Eng. J. Med., 349: 474-485.
20. Lott, J.A. and P.L. Wolf, 1986. Alanine and aspartate aminotransferase. Clinical Enzymology. Field Rich and Associates, New York, pp: 111- 138.
21. Martinez, E., J.L. Blanco, A. Arnaiz, J.B. Peres-Cuevas, A. Mocroft, A. Cruceta, M.A. Marcos, A. Milinkovic and M.A. Garcia-Viejo, 2001. Hepatotoxicity in HIV-1 infected patients receiving nevirapine-containing antiretroviral therapy. AIDS, 15: 1261-1268.
22. Perry, B.W., B.T. Doumas and D.D. Bayse, 1983. A candidate reference method for determination of bilirubin in serum: Test for transferability. Clin. Chem., 29: 297-301.
23. Piliero, P.J. and B. Purdy, 2001. Nevirapine-induced hepatitis: A case series and review of the literature. AIDS Read, 11: 379-382.
24. Reed, J.L., 2001. Apoptosis regulating proteins as targets for drug discovery. Trends Mol. Med., 7: 314-319.
25. Reisler, R., S. Liou, J. Servoss, G. Robbins, D. Theodore, R. Murphy and R. Chung, 2001. Incidence of hepatotoxicity and mortality in 21 adults antiretroviral treatment trials. Program and Abstracts of the 1st International AIDS Conference on HIV Pathogenesis and Treatment, Buenos Aires, Argentina. Abstract, 43: 8-11.
26. Reitman, D. and S. Frankel, 1957. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am. J. Clin. Pathol., 28: 56-59.
27. Ringer, D.H. and L. Dabich, 1979. Haematological and Biochemical Parameters. In: The Laboratory Rats. Baker, H.J., J.R. Lindsay and S.H. Weisbroth (Eds.), Vol. 1 Acad. Press, London, pp: 105-116.
28. Schambelan, M., C. Benson and A. Carr, 2002. Acquired Immune Deficiency Syndrome. International AIDS Society. USA Panel, 9: 30-32.
29. Schreiber, M., 2004. Laboratory assessment of liver functions. www.pathology ubc.ca/path425/systemic pathology/liver and biliary tract. Accessed 05/09/2005.
30. Speech, H.J. and H. Liehr, 1983. Of what values are SGOT/SGPT, GGT/AP and IgG/Ig A ratios in the differential diagnosis of advanced liver diseases? Z. Astroenterol., 21: 89-96.
31. Sulkwoski, M.S., D.L. Thomas, R.E. Chaisson and R.D. Moore, 2000. Hepatotoxicity associated with antiretroviral therapy in adults infected with HIV and the role of hepatitis C or B virus infection. JAMA., 283: 74-80.
32. Umar, R.A., M.J. Ladan, S.W. Hassan, Y. Sa'idu, A.Y. Abbas and I.B. Oduolisaeme, 2007. Administration of antiretroviral drugs (Lamivudine, Nevirapine and Stavudine) has no untoward effect on haematological profile in albino rats. Asian J. Biochem., 2: 147-151.
33. Walensky, R.P., A..D. Paltiei and E. Casina, 2006. The survival benefits of AIDS treatment in the United States. J. Infect. Dis., 194: 1-9.
34. Whicher, J., R.F. Ritchie and A.V. Johnson, 1994. New International Reference Preparation for Proteins in Human Serum (RPPHS). Clin. Chem., 40: 934-938.
35. Wolf, L.D., 2003. Update on the Clinical Liver Function Testing. San Diego Health Sy3tem, University of California, USA.
36. WHO, 2005. World's AIDS and Tuberculosis Situation. Tuberculoois Department. WHO, Geneva.
37. Wright, P.J. and D.T. Plummer, 1974. The use of urinary enzyme measurements to detect renal changes caused by nephrotoxic compounds. Biochem. Pharmacol., 12: 65-68.
38. Yun, O.H., R.A. Okerholm and F.P. Guengerich, 1993. Oxidation of the antihistamine drug teefenadrine in human liver microsomes: Role of cyt. P450 3A4 in N-dealkylation and C-hydroxylation of drug. Metab. Dispos., 21: 403-409.